Evidence map›Paper›PMID 17132718›Full record

ArticleBlood2007

A novel human B cell subpopulation representing the initial germinal center population to express AID.

Grant R Kolar, Darshna Mehta, Rosana Pelayo, J Donald Capra

Abstract read
In one paragraph

Article in Blood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.Forum on immunopathological diseases and therapeutics · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Molecular pathogenesis of mantle cell lymphoma.The Journal of clinical investigation · 2012
    Review
  17. Review
  18. New helping friends for B cells.European journal of immunology · 2012
    Review
  19. Advances in human B cell phenotypic profiling.Frontiers in immunology · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Grant R KolarProgram in Molecular Immunogenetics, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Darshna Mehta
Rosana Pelayo
J Donald Capra

Funding

THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CENTOLA, MICHAEL B · 2000 to 2009
$21.5M
NCRR NIH HHS P20 RR015577NCRR NIH HHS SP20 RR015577-07
6 · The paper itself

Abstract

We have identified a novel mature human B-cell subpopulation in the human tonsil that has characteristics of both naive B cells and germinal center B cells including the expression of activation-induced cytidine deaminase (AID), which is essential for the process of immunoglobulin somatic hypermutation and class-switch recombination. These cells are clearly somatically hypermutated, albeit modestly. Their phenotype (IgD(+)CD38(-)CD23(-)FSC(hi)CD71(+)) is unique and suggests they may be intermediate between both naive and germinal center cells. Morphologically they are also distinct from other B-cell subpopulations. The evidence presented suggests these cells may be the founder cells of the germinal center reaction (a pro-GC cell) and may be the normal counterpart of the mantle cell lymphoma cell.

Indexed as

ADP-ribosyl Cyclase 1AICDA (Activation-Induced Cytidine Deaminase)BiomarkersB-LymphocytesCell ShapeCoculture TechniquesCytidine DeaminaseGerminal CenterHumansImmunoglobulin DLymphocyte CountMutationPhenotypeReceptors, IgETranscription, GeneticADP-ribosyl Cyclase 1AICDA (Activation-Induced Cytidine Deaminase)BiomarkersCytidine DeaminaseImmunoglobulin DReceptors, IgE

Identifiers

PMID17132718
PMCPMC1852199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.